Development of a clinically viable MRGPRX4 inverse agonist for cholestatic itch treatment
{{output}}
Chronic itch, particularly in cholestatic and uremic conditions, poses a notable clinical burden, yet treatment options remain inadequate. MRGPRX4 (hX4), a bile-acid-sensing G-protein-coupled receptor predominantly expressed in human sensory neurons, has emerg... ...
